Utility of platelet indices in diagnosing the underlying cause of thrombocytopenia due to accelerated platelet destruction

  • Sushma Yalavarthi department of Pathology, Mamata Medical college, Khammam, Telangana, India
  • Nirvana Rasaily Halder department of Pathology, Mamata Medical college, Khammam, Telangana, India
  • Aparna Pagidikalava department of Pathology, Mamata Medical college, Khammam, Telangana, India
Keywords: Platelet indices, Thrombocytopenia due to accelerated destruction, Immune, Nonimmune, Miscellaneous.


Background: Thrombocytopenia is a common clinical manifestation of many diseases and has numerous causes, including decreased bone marrow production, increased spleen sequestration, and accelerated destruction of platelets. Among the various aetiologies, Accelerated platelet destruction is the most common cause. Distinction between the various aetiological categories of thrombocytopenia is usually made by invasive bone marrow examination. Some studies stated that Platelet indices were altered in various causes of thrombocytopenia and helpful in discriminating the causes. we aim, to know the role of platelet indices in determining the underlying cause of thrombocytopenia due to platelet destruction.Methods:  30 Healthy controls and 145 patients (study group) with thrombocytopenia (platelet count <150x109) were included in the study. Thrombocytopenia due to decreased bonemarrow production and artefactual thrombocytopenia were excluded. The study group was divided into 3groups. Group 1 includes immune thrombocytopenia, Group 2 having thrombocytopenia of non immunological causes and Group 3 includes miscellaneous causes. Clinical features, Platelet counts and platelet indices were studied and statistical analysis was performed. Result: In all the groups of thrombocytopenia due to accelerated platelet destruction, MPV and P-LCR were significantly higher; P-LCC was significantly lower than healthy controls. There was no significant variation of PDW in NonImmune thrombocytopenia and miscellaneous groups, but PDW was significantly lower in immune thrombocytopenia than healthy controls.Conclusion: Platelet indices should be considered in the diagnosis of thrombocytopenia due to accelerated destruction of any cause.  Among the platelet indices, PDW can be useful for a positive diagnosis of immunological thrombocytopenia.DOI:10.21276/APALM.1717

Author Biography

Sushma Yalavarthi, department of Pathology, Mamata Medical college, Khammam, Telangana, India


1. Levine SP. Thrombocytopenia: Pathophysiology and classification. In: Greer JP, Forester J, Leukens JN, Rodgers GM, Paraskevas F, Glader B editors. Wintrobe's Clinical Hematology, 11th ed. Philadelphia: Lippincott Williams& Wilkins; 2004.1529.

2. Mikias N, Aster T, Amha GM, et al. Diagnostic predictive value of platelet indices for discriminating hypo productive versus immune thrombocytopenia purpura in patients attending a tertiary care teaching hospital in Addis Ababa, Ethiopia. BMC Hematol. 2016;16:18.

3. Yasemin UB, Murat P, Huysa K, et al. .The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review. Biochem Med . 2016;26:178–193.

4. Demirin H, Ozhan H, Ucgun T, Celer A, Bulur S, Cil H, et al. Normal range of mean platelet volume in healthy subjects: insight from a large epidemiologic study. Thromb Res. 2011;128: 358–60.

5. Wiwanitkit V. Plateletcrit, mean platelet volume, platelet distribution width: its expected values and correlation with parallel red blood cell parameters. Clin Appl Thromb Hemost. 2004;10:175–8.

6. Maluf CB, Barreto SM, Vidigal PG. Standardization and reference intervals of platelet volume indices: Insight from the Brazilian longitudinal study of adult health (ELSA-BRASIL). Platelets. 2015;26:413–20.

7. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010;14:28–32.

8. Akarsu S, Taskin E, Kilic M, Ozdiller S, Gurgoze MK, et al. The effects of different infectious organisms on platelet counts and platelet indices in neonates with sepsis: is there an organism-specific response? J Trop Pediatr.2005;51:388–91.

9. Borkataky S, Jain R, Gupta R, Singh S, Krishnan G, Gupta K, et al. Role of platelet volume indices in the differential diagnosis of thrombocytopenia: a simple and inexpensive method. Hematology 2009;14:182-186.

10. Kaito K, Otsubo H, Usui N, Yoshida M, Tanno J, Kurihara E, et al. Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol 2005;128:698-702.

11. Ntaios G, Papadopoulos A, Chatzinikolaou A, Saouli Z, Karalazou P, Kaiafa G, et al. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Haematol 2008;119:173-177.

12. Shah AR, Chaudhari SN, Shah MH, et al. Role of platelet parameters in diagnosing various clinical conditions. Natl J Med Res 2013;3:162-165.

13. Elsewefy DA, Farweez BA, Ibrahim RR. Platelet indices: consideration in thrombocytopenia.Egyptian Journal of Hamatology 2014;39:134-138.

14. Osselaer JC, Jamart J, Scheiff JM. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem. 1997;43:1072–6.

15. Babu E, Basu D. Platelet large cell ratio in the differential diagnosis of abnormal platelet counts. Indian J Pathol Microbiol 2004;47:202-205.

16. Sachdev R, Tiwari AK, Goel S, Raina V, Sethi M. Establishing biological reference intervals for novel platelet parameters (immature platelet fraction, high immature platelet fraction, platelet distribution width, platelet large cell ratio, platelet-X, plateletcrit, and platelet distribution width) and their correlations among each other. Indian J Pathol Microbiol. 2014;57:231–5.

17. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-186.
Original Article